Drugs / BI 639667
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02133482 | Jul → Oct 2014 | — | Boehringer Ingelheim | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 639667 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02133482 ↗ |
| Known as | CCR1 ANTAGONIST 8 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4456123 ↗ |
| Modality | Small molecule | — CHEMBL4456123 ↗ |
| Route | Oral | “following oral administration of single rising doses” NCT02133482 ↗ |